Reference: TM6SF2 rs58542926 CC | Effect on annual outpatient visits, % Bootstrap (95 %-CI),a | Hospitalization, OR Bootstrap (95 %-CI) | Effect on annual inpatient days, % Bootstrap (95 %-CI),a |
---|---|---|---|
Model 1 (age, sex, school education, income, alcohol intake, smoking status, eGFR) | |||
CT | +53.04 (+18.33, +115.29)* | 1.93 (0.67, 5.03) | +85.33 (+18.94, +188.78)* |
TT | +67.56 (+28.28, +134.59)* | 1.81 (0.59, 5.08) | +123.74 (+33.14, +275.97)* |
Model 2: model 1 + Functional Comorbidity Index | |||
CT | +57.82 (+23.62, +113.43)* | 1.96 (0.68, 5.56) | +94.01 (37.83, 173.1)* |
TT | +69.79 (+31.60, 145.43)* | 1.82 (0.72, 5.75) | +133.49 (51.86, 259.0)* |
Model 3: Model 2 + hepatic steatosis | |||
CT | +56.54 (+15.03, +110.21)* | 1.93 (0.78, 5.44) | +93.36 (+35.99, +174.93)* |
TT | +69.28 (+24.58, +130.01)* | 1.80 (0.68, 5.10) | +132.83 (+51.83, +257.1)* |
Model 4: Model 2 + ALT | |||
CT | +56.51 (+19.96, +112.33)* | 1.91 (0.65, 4.98) | +91.50 (+40.32, +161.36)* |
TT | +69.65 (+31.38, 136.92)* | 1.79 (0.63, 5.04) | +131.08 (+53.60, 247.63)* |
Model 5: Model 2 + ferritin | |||
CT | +55.75 (+21.37, +106.99)* | 1.83 (0.63, 5.38) | +94.00 (+37.65, +173.43)* |
TT | +69.09 (+31.92, +134.08)* | 1.73 (0.56, 4.98) | +133.47 (+52.00, +259.61)* |
Model 6: Model 1 + metabolic syndrome | |||
CT | +45.21 (+7.26, +107.45)** | 1.81 (0.65, 5.34) | +74.58 (+13.38, +168.79)** |
TT | +60.48 (+14.54, 124.9)* | 1.73 (0.68, 5.63) | +114.92 (+30.05, +255.17)* |
Model 7: Model 1 + waist circumference | |||
CT | +49.27 (7.63, +95.57)* | 1.92 (0.80, 5.12) | +90.50 (+32.88, +73.10)* |
TT | +63.27 (+23.38, +138.34)* | 1.79 (0.70, 4.71) | +131.9 (+47.56, 264.6)* |
Model 8: Model 1 + BMI | |||
CT | +50.28 (+12.46, 106.67)* | 1.92 (0.58, 5.49) | +92.70 (+27.32, 191.65)* |
TT | +64.73 (+23.39, +119.28)* | 1.80 (0.55, 5.21) | +133.3 (+41.87, 283.35)* |
Model 9: Model 1 + triglycerides | |||
CT | +50.08 (+15.38, +195.16)* | 1.89 (0.68, 5.61) | +83.47 (+16.35, +189.29)* |
TT | +65.92 (+23.72, +120.61)* | 1.79 (0.62, 5.14) | +119.17 (+29.87, 269.89)* |
Model 10: Model 1 + HDL cholesterol | |||
CT | +50.69 (+15.98, +238.0)* | 1.89 (0.69, 5.14) | +77.12 (+11.73, +180.78)** |
TT | +66.26 (+26.23, +158.59)* | 1.75 (0.64, 5.04) | +116.1 (+27.42, +266.50)* |
Model 11: Model 1 + systolic blood pressure | |||
CT | +53.16 (+22.27, +141.1)* | 1.93 (0.60, 5.09) | +84.63 (+18.88, +186.75)* |
TT | +66.64 (+30.17, 167.93)* | 1.77 (0.51, 4.73) | +124.11 (+33.36, +276.62)* |
Model 12: Model 1 + serum glucose | |||
CT | +50.51 (+13.57, +105.38)* | 1.91 (0.64, 5.50) | +82.57 (+17.68, 183.2)* |
TT | +63.36 (+21.72, 116.9)* | 1.81 (0.58, 5.47) | +121.82 (+32.44, 271.50)* |
Model 13: Model 1 + hbA1c | |||
CT | +53.38 (+21.00, +109.69)* | 1.94 (0.82, 5.74) | +85.09 (+18.75, +188.49)* |
TT | +67.02 (+29.44, 23.17)* | 1.82 (0.72, 5.52) | +122.18 (+32.83, 275.01)* |